These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 1875158

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Magnesium pemoline and dextroamphetamine: a controlled study in children with minimal brain dysfunction.
    Conners CK, Taylor E, Meo G, Kurtz MA, Fournier M.
    Psychopharmacologia; 1972; 26(4):321-36. PubMed ID: 4508756
    [No Abstract] [Full Text] [Related]

  • 44. Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
    Marcus SC, Durkin M.
    J Am Acad Child Adolesc Psychiatry; 2011 May; 50(5):480-9. PubMed ID: 21515197
    [Abstract] [Full Text] [Related]

  • 45. What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder?
    Hoza B, Mrug S, Gerdes AC, Hinshaw SP, Bukowski WM, Gold JA, Kraemer HC, Pelham WE, Wigal T, Arnold LE.
    J Consult Clin Psychol; 2005 Jun; 73(3):411-23. PubMed ID: 15982139
    [Abstract] [Full Text] [Related]

  • 46. Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder.
    Chacko A, Pelham WE, Gnagy EM, Greiner A, Vallano G, Bukstein O, Rancurello M.
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):249-57. PubMed ID: 15725969
    [Abstract] [Full Text] [Related]

  • 47. Stimulant medication and short attention span: a clinical approach.
    Davy T, Rodgers CL.
    J Dev Behav Pediatr; 1989 Dec; 10(6):313-8. PubMed ID: 2513337
    [Abstract] [Full Text] [Related]

  • 48. Treatment of ADDH in mentally retarded children: a preliminary study.
    Payton JB, Burkhart JE, Hersen M, Helsel WJ.
    J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):761-7. PubMed ID: 2676965
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK, Julius JR, Breen TJ, Blethen SL.
    Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Effects of methylphenidate on impulsive responding in children with attention-deficit hyperactivity disorder.
    Malone MA, Swanson JM.
    J Child Neurol; 1993 Apr; 8(2):157-63. PubMed ID: 8505479
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH, Zaw F, Handley SL.
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [Abstract] [Full Text] [Related]

  • 58. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, Halperin JM, Newcorn JH.
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [Abstract] [Full Text] [Related]

  • 59. MBD: advanced in understanding many bothersome dilemmas.
    Seals JR.
    Adv Pediatr; 1976 Sep; 23():113-49. PubMed ID: 795279
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.